We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
-3.74%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$826M
AUM Growth
-$12.2M
Cap. Flow
+$46.8M
Cap. Flow %
5.67%
Top 10 Hldgs %
31.84%
Holding
2,811
New
180
Increased
1,184
Reduced
708
Closed
182

Sector Composition

Rank Sector Weight
1 Technology 13.18%
2 Healthcare 7.19%
3 Consumer Staples 7.15%
4 Financials 6.93%
5 Consumer Discretionary 5.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONL
2351
Orion Office REIT
ONL
$150M
$1K ﹤0.01%
71
-296
-81% -$4.99K
ORRF icon
2352
Orrstown Financial Services
ORRF
$836M
$1K ﹤0.01%
23
OSUR icon
2353
OraSure Technologies
OSUR
$273M
$1K ﹤0.01%
111
-29
-21% -$232
PAHC icon
2354
Phibro Animal Health
PAHC
$1.43B
$1K ﹤0.01%
+44
New +$889
PBI icon
2355
Pitney Bowes
PBI
$2.46B
$1K ﹤0.01%
191
PETS icon
2356
PetMed Express
PETS
$42.1M
$1K ﹤0.01%
57
+8
+16% +$207
PFBC icon
2357
Preferred Bank
PFBC
$1.23B
$1K ﹤0.01%
20
PFS icon
2358
Provident Financial Services
PFS
$3.11B
$1K ﹤0.01%
38
PKE icon
2359
Park Aerospace
PKE
$785M
$1K ﹤0.01%
97
PLCE icon
2360
Children's Place
PLCE
$52.9M
$1K ﹤0.01%
17
PNTG icon
2361
Pennant Group
PNTG
$1.44B
$1K ﹤0.01%
71
+23
+48% +$384
PRGO icon
2362
Perrigo
PRGO
$1.4B
$1K ﹤0.01%
24
-4
-14% -$152
PUMP icon
2363
ProPetro Holding
PUMP
$1.32B
$1K ﹤0.01%
103
-56
-35% -$669
QS icon
2364
QuantumScape Corp
QS
$3.19B
$1K ﹤0.01%
50
+4
+9% +$69
RARE icon
2365
Ultragenyx Pharmaceutical
RARE
$2.65B
$1K ﹤0.01%
22
-37
-63% -$2.57K
RDNT icon
2366
RadNet
RDNT
$4.84B
$1K ﹤0.01%
54
REAL icon
2367
The RealReal
REAL
$1.4B
$1K ﹤0.01%
119
-616
-84% -$5.45K
RLGT icon
2368
Radiant Logistics
RLGT
$415M
$1K ﹤0.01%
93
-52
-36% -$344
RLI icon
2369
RLI Corp
RLI
$5.88B
$1K ﹤0.01%
24
-8
-25% -$422
RLMD icon
2370
Relmada Therapeutics
RLMD
$546M
$1K ﹤0.01%
20
RLX icon
2371
RLX Technology
RLX
$2.49B
$1K ﹤0.01%
462
-567
-55% -$1.69K
RMAX icon
2372
RE/MAX Holdings
RMAX
$207M
$1K ﹤0.01%
34
RMR icon
2373
The RMR Group
RMR
$348M
$1K ﹤0.01%
17
-297
-95% -$9.27K
RNAM
2374
DELISTED
Avidity Biosciences
RNAM
$1K ﹤0.01%
+29
New +$493
RXT icon
2375
Rackspace Technology
RXT
$980M
$1K ﹤0.01%
121
-1
-0.8% -$12

Similar funds

Quadrant Capital Group's Q1 2022 Portfolio in Review

As of Q1 2022, Quadrant Capital Group held 2,811 positions worth $826M, down 1.5% from $838M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Quadrant Capital Group deployed $46.8M of net new capital in Q1 2022, opening 180 new positions and adding to 1,184 existing holdings. Its largest new stake was RiverNorth Opportunistic Municipal Income Fund: 900,000 shares worth $900K.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was iShares Core 1-5 Year USD Bond ETF, an estimated $7.86M trimmed.

  • Quadrant Capital Group's largest Q1 2022 buy was RiverNorth Opportunistic Municipal Income Fund: 900,000 shares worth $900K.
  • Quadrant Capital Group added most to Vanguard Short-Term Bond ETF in Q1 2022, an estimated $9.88M increase.
  • Quadrant Capital Group's biggest Q1 2022 reduction was iShares Core 1-5 Year USD Bond ETF, cutting an estimated $7.86M.
  • Quadrant Capital Group fully exited Royal Dutch Shell PLC ADS Class A in Q1 2022, selling an estimated $781K.
  • Quadrant Capital Group's ten largest holdings make up 32% of its $826M portfolio in Q1 2022.
  • Quadrant Capital Group opened 180 new positions and closed 182 in Q1 2022.
  • Quadrant Capital Group's portfolio value fell 1.5% quarter-over-quarter to $826M.

Based on Quadrant Capital Group's 13F filing for Q1 2022, filed 6 May 2022.